Compounded treatments for erectile dysfunction: a common complication of diabetes

Compounded treatments for erectile dysfunction: a common complication of diabetes

Erectile dysfunction is a very common complication of diabetes; as many as 50% to 80% of men with diabetes experience some degree of erectile dysfunction. Erectile dysfunction in men with diabetes mellitus usually is a result of the vascular and autonomic dysfunctions that often accompany uncontrolled hyperglycemia. A number of treatment options can be offered to a patient experiencing this complication. Compounding allows for specialized dosage forms of medications; with the help of an attentive physician and a compounding pharmacist, successful treatment of erectile dysfunction can become a reality.

Did Anti-biotics Make Superbug MRSA Stronger?

Did Anti-biotics Make Superbug MRSA Stronger?

The world is facing the threat of ‘superbugs’ as these bacteria dubbed as methicillin-resistant Staphylococcus aureus (MRSA) have evolved into one of the most difficult-to-treat pathogens. MRSA is a bacteria that is resistant to many antibiotics. In the external community, most MRSA infections are skin infections. In medical facilities, MRSA causes life-threatening bloodstream infections, pneumonia and surgical site infections. A new study suggests that treatment with the wrong antibiotic could make MRSA-induced infections worse.

Research Shows New Cholesterol-Lowering Drugs Could Be More Effective than Statins

Research Shows New Cholesterol-Lowering Drugs Could Be More Effective than Statins

Researchers reported the first evidence that a new class of drugs known to dramatically lower cholesterol may also reduce risk of heart attacks, strokes and other serious consequences of cardiovascular disease. The drugs represent the most important new class of cholesterol-lowering medications since the first statin was approved in 1987.

New Medication Makes Opioid Treatment Less Risky for Chronic Pain Sufferers

New Medication Makes Opioid Treatment Less Risky for Chronic Pain Sufferers

BioDelivery Sciences International Inc recently announced that the U.S. Food and Drug Administration had approved its opioid treatment for chronic pain. Belbuca is an opioid film patch and aims to treat patients with chronic pain who need round-the-clock treatment and for whom current alternatives do not suffice. Belbuca has the advantages of lower possibility for abuse and less chance of causing constipation. Physicians will be able to prescribe the medication for 6 months at a time rather than by the month.

New Facts About NSAIDs

New Facts About NSAIDs

People with joint conditions such as arthritis often take over the counter NSAIDs such as ibuprofen to relieve joint pain and inflammation. However, taking oral NSAIDs often can be harmful to your health. The FDA black box warning states that NSAIDs may cause an increased risk of heart attack, stroke, high blood pressure, gastric ulcers, and gastric bleeding. Transdermal creams or gels can be used to deliver NSAIDs through the skin into underlying joints or tissues to relieve pain and inflammation. They offer the advantage of being more effective at relieving pain and with fewer harmful side effects.

^
Font Resize
Contrast
X

Forgot Password?

Join Us

Password Reset
Please enter your e-mail address. You will receive a new password via e-mail.